Skip to main content

. 1964 Feb;43(2):279–284. doi: 10.1172/JCI104912

Endotoxin Shock in the Primate: Treatment with Phenoxybenzamine^{^*}

James A Vick ¹

PMCID: PMC289521 PMID: 14162536

279

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ALICAN F., HARDY J. D. Sympatho-adrenal system in endotoxin shock. Surg Forum. 1962;13:8–10. [PubMed] [Google Scholar]
COTZIAS G. C. Manganese versus magnesium: why are they so similar in vitro and so different in vivo? Fed Proc. 1961 Sep;20(3):98–103. [PubMed] [Google Scholar]
GILBERT R. P. Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev. 1960 Apr;40:245–279. doi: 10.1152/physrev.1960.40.2.245. [DOI] [PubMed] [Google Scholar]
HINSHAW L. B., BRADLEY G. M., CARLSON C. H. Effect of endotoxin on renal function in the dog. Am J Physiol. 1959 May;196(5):1127–1131. doi: 10.1152/ajplegacy.1959.196.5.1127. [DOI] [PubMed] [Google Scholar]
HINSHAW L. B., SPINK W. W., VICK J. A., MALLET E., FINSTAD J. Effect of endotoxin on kidney function and renal hemodynamics in the dog. Am J Physiol. 1961 Jul;201:144–148. doi: 10.1152/ajplegacy.1961.201.1.144. [DOI] [PubMed] [Google Scholar]
HINSHAW L. B., VICK J. A., CARLSON C. H., FAN Y. L. Role of histamine in endotoxin shock. Proc Soc Exp Biol Med. 1960 Jul;104:379–381. doi: 10.3181/00379727-104-25843. [DOI] [PubMed] [Google Scholar]
HINSHAW L. B., VICK J. A., JORDAN M. M., WITTMERS L. E. Vascular changes associated with development of irreversible endotoxin shock. Am J Physiol. 1962 Jan;202:103–110. doi: 10.1152/ajplegacy.1962.202.1.103. [DOI] [PubMed] [Google Scholar]
IAMPIETRO P. F., HINSHAW L. B., BRAKE C. M. Effect of an adrenergic blocking agent on vascular alterations associated with endotoxin shock. Am J Physiol. 1963 Apr;204:611–614. doi: 10.1152/ajplegacy.1963.204.4.611. [DOI] [PubMed] [Google Scholar]
LILLEHEI R. C., MACLEAN L. D. The intestinal factor in irreversible endotoxin shock. Ann Surg. 1958 Oct;148(4):513–525. doi: 10.1097/00000658-195810000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
NICKERSON M. Factors of vasoconstriction and vasodilation in shock. J Mich State Med Soc. 1955 Jan;54(1):45–passim. [PubMed] [Google Scholar]
ROSENBERG J. C., LILLEHEI R. C., MORAN W. H., ZIMMERMANN B. Effect of endotoxin on plasma catechol amines and serum serotonin. Proc Soc Exp Biol Med. 1959 Nov;102:335–337. doi: 10.3181/00379727-102-25238. [DOI] [PubMed] [Google Scholar]
SPINK W. W. Endotoxin shock. Ann Intern Med. 1962 Oct;57:538–552. doi: 10.7326/0003-4819-57-4-538. [DOI] [PubMed] [Google Scholar]
SPINK W. W., VICK J. Canine endotoxin shock: reversal with aldosterone and angiotensin II (hypertensin). Proc Soc Exp Biol Med. 1962 Mar;109:521–522. doi: 10.3181/00379727-109-27255. [DOI] [PubMed] [Google Scholar]
VICK J. A., LAFAVE J., MACLEAN L. D. RENAL FAILURE ASSOCIATED WITH ENDOTOXIN SHOCK. Minn Med. 1963 Sep;46:855–857. [PubMed] [Google Scholar]
VICK J., SPINK W. W. Supplementry role of hydralazine in reversal of endotoxin shock with metaraminol and hydrocortisone. Proc Soc Exp Biol Med. 1961 Feb;106:280–283. doi: 10.3181/00379727-106-26309. [DOI] [PubMed] [Google Scholar]
WEIL M. H., MILLER B. S. Experimental studies on therapy of circulatory failure produced by endotoxin. J Lab Clin Med. 1961 May;57:683–693. [PubMed] [Google Scholar]
WEIL M. H., SUDRANN R. B., SHUBIN H. Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy. Calif Med. 1962 Feb;96:86–88. [PMC free article] [PubMed] [Google Scholar]
ZINGG W., NICKERSON M., CARTER S. A. Effect of hydralazine on survival of dogs subjected to hemorrhagic shock; preliminary report. Surg Forum. 1958;9:22–24. [PubMed] [Google Scholar]

ACTIONS

RESOURCES